Delivery Order SPE2DB20D3103-SPE2DB25FP7L7
Award Date 8/5/25
Potential Completion Date 8/6/25
Potential Value $25K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $3,188.64 to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 ml pen injections on July 22, 2025, with an ultimate completion date of July 23, 2025. This is a firm fixed price, non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency has awarded a delivery order valued at $2,425.15 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pens, a glucagon-like peptide-1 (GLP-1) receptor agonist used in diabetes and weight management treatment. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and is scheduled for completion by July 24, 2025. The award was issued on July 23, 2025, with performance to be executed at AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,287.74 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens on August 7, 2025, with completion targeted for August 8, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's broader Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $6,750.31 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injections on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $4.5K delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Zepbound 12.5 mg/0.5 mL pen injectors, with a completion date of July 29, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion through December 2026. The place of performance is located in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $10,090.60 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens on August 7, 2025. This firm fixed-price delivery order is non-competitive and represents a single shipment of the diabetes and weight management medication to support federal healthcare requirements. The contract will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, with an ultimate completion date of August 8, 2025....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,155.44 to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 mL pen injectors, a medication used in diabetes and weight management treatment. This firm fixed-price delivery order was awarded on July 31, 2025, with an ultimate completion date of August 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was awarded without a set-aside designation,...
- The Defense Logistics Agency (DLA) awarded a delivery order totaling $3,115.90 to AmerisourceBergen Drug Corp for the supply of Zepbound 12.5 mg/0.5 ml pen (0.5 ml), a pharmaceutical product used in diabetes and weight management treatment. This competitively awarded, firm fixed-price delivery order was issued on July 25, 2025, with an ultimate completion date of July 28, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The contract carries no...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Zepbound 12.5 mg/0.5 mL pens, a GLP-1 receptor agonist medication used for weight management. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $3,050.40 and an ultimate completion date of August 4, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $6,970.68 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injectors. The contract is a firm fixed-price delivery order with an ultimate completion date of July 21, 2025, and will be fulfilled at the contractor's Conshohocken, Pennsylvania facility. This award represents a non-set-aside competitive procurement, demonstrating AmerisourceBergen's continued capability to meet federal pharmaceutical...